Performance and Accuracy of an AI Enhanced Smart Watch Single Lead ECG
PROCESS
PeRfOrmance and ACcuracy of an artifiCial Intelligence Enhanced Smart Watch Single Lead ECG (PROCESS)
PROCESS
PeRfOrmance and ACcuracy of an artifiCial Intelligence Enhanced Smart Watch Single Lead ECG (PROCESS)
Sponsor study identifier
observational
1,000
1 country
1
Study Start
November 5, 2021
Actual (reported)Primary Completion
November 2, 2022
Actual (reported)Study Completion
November 2, 2022
Actual (reported)The purpose of this study is to show the artificial intelligence enhanced single-lead ECG Apple Watch has similar, robust performance comparable to an AI enhanced 12 lead ECG and AI enhanced single lead (LI) of a 12 lead ECG.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2, 2022
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 5, 2021
Actual (reported)July 5, 2022
Actual (reported)July 11, 2022
Actual (reported)November 2, 2022
Actual (reported)November 2, 2022
Actual (reported)Comparison of 12 lead ECG features to single-lead watch-based ECG features
The ECG interval differences (in milliseconds) between 12 Lead and collected single-lead watch-based ECG for PR, QRS, QT intervals will be determined and compared for each patient.
12 months
Arrhythmia comparison of 12 lead ECG to single-lead watch-based ECG
A physician interpretation of patients' 12 lead ECG and single-lead watch-based ECG will be performed to determined underlying rhythm (i.e. sinus rhythm, atrial fibrillation etc) from each, and the results from these modalities will be compared.
12 months
Arrhythmia classification by physician overread of single-lead watch-based ECG
12 months
Artificial intelligence detection of heart failure by single-lead watch-based ECG
12 months
Artificial intelligence detection of silent/paroxysmal atrial fibrillation by single-lead watch-based ECG
12 months
Artificial intelligence detection of aortic stenosis by single-lead watch-based ECG
12 months
Patients who are undergoing routine clinical evaluation with a 12 lead ECG recording ordered at the Mayo Clinic ECG lab.
Ambulatory patients who are undergoing a clinically ordered electrocardiogram in the Mayo Clinic outpatient ECG lab.
Mayo Clinic
Rochester, Minnesota, 55905, United States
Itzhak Zachi Attia, PhD
Mayo Clinic
1,000 participants (actual enrollment reported by the registry).
First Submitted
July 5, 2022
First Posted
July 11, 2022
Study Start
November 5, 2021
Actual (reported)Registry for Mayo Clinic Adult Congenital Heart Disease Control Population
Contact the study team to confirm eligibility.
Primary Completion
November 2, 2022
Actual (reported)Study Completion
November 2, 2022
Actual (reported)Last Updated
December 28, 2022
Record last verified: 2022-12
Due to patient confidentiality and IRB rules, we will not make individual patient data available
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: